Ono Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 5.73% vs -0.41% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 116.35% vs -136.53% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "118,749.00",
          "val2": "112,309.00",
          "chgp": "5.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "22,017.00",
          "val2": "1,074.00",
          "chgp": "1,950.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1,132.00",
          "val2": "2,459.00",
          "chgp": "-53.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,041.00",
          "val2": "-6,367.00",
          "chgp": "116.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "104.50%",
          "val2": "-68.20%",
          "chgp": "17.27%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 5.94% vs -3.14% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 39.36% vs -60.82% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "515,785.00",
          "val2": "486,871.00",
          "chgp": "5.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "141,087.00",
          "val2": "90,278.00",
          "chgp": "56.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2,163.00",
          "val2": "1,635.00",
          "chgp": "32.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,656.00",
          "val2": "-1,645.00",
          "chgp": "-0.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "69,911.00",
          "val2": "50,166.00",
          "chgp": "39.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "200.30%",
          "val2": "130.20%",
          "chgp": "7.01%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

118,749.00

112,309.00

5.73%

Operating Profit (PBDIT) excl Other Income

22,017.00

1,074.00

1,950.00%

Interest

1,132.00

2,459.00

-53.97%

Exceptional Items

0.00

0.00

Consolidate Net Profit

1,041.00

-6,367.00

116.35%

Operating Profit Margin (Excl OI)

104.50%

-68.20%

17.27%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 5.73% vs -0.41% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 116.35% vs -136.53% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

515,785.00

486,871.00

5.94%

Operating Profit (PBDIT) excl Other Income

141,087.00

90,278.00

56.28%

Interest

2,163.00

1,635.00

32.29%

Exceptional Items

-1,656.00

-1,645.00

-0.67%

Consolidate Net Profit

69,911.00

50,166.00

39.36%

Operating Profit Margin (Excl OI)

200.30%

130.20%

7.01%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 5.94% vs -3.14% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 39.36% vs -60.82% in Mar 2025

All Annual Results